Meridian Bioscience (VIVO) Reports In-Line Q4 EPS
Tweet
Share
E-mailGet Alerts VIVO Hot Sheet
Price: $4.59 --0%
Financial Fact:
AVERAGE NUMBER OF COMMON SHARES OUTSTANDING - DILUTED: -84.82M
Today's EPS Names:
OTLK, EGRX, MOVE, More
Financial Fact:
AVERAGE NUMBER OF COMMON SHARES OUTSTANDING - DILUTED: -84.82M
Today's EPS Names:
OTLK, EGRX, MOVE, More
Join SI Premium – FREE
Meridian Bioscience (Nasdaq: VIVO) reported Q4 EPS of $0.19, in-line with the analyst estimate of $0.19. Revenue for the quarter came in at $48 million versus the consensus estimate of $46.2 million.
Meridian Bioscience reaffirmed FY2015 guidance.
For earnings history and earnings-related data on Meridian Bioscience (VIVO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Star Equity Holdings (STRR) Misses Q2 EPS by 8c
- Acurx Pharmaceuticals (ACXP) Tops Q2 EPS by 4c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
